Showing results (311-320 of 439) with videos related to
Sort By:
Pageof 44
Metabolism Open|April 20, 2026
COVID-19 and metabolic health: Lessons from a global pandemicMaria Dalamaga, Irene Karampela, Junli LiuMetabolism Open|April 9, 2026
Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trialPrabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.Metabolism Open|March 26, 2026
Macrophage microRNAs integrating lipid metabolism and inflammation: Implications for atherosclerosisFan Fan, De-Jing ShangMetabolism Open|May 1, 2026
Bioactive fractions of Solanum aethiopicum leaves improve glucose homeostasis, lipid metabolism and oxidative stress in experimental type 2 diabetesSomon Regine Tuem, Jules Christophe Koule Manz, Jean Valery François Nsoga, et al.Metabolism Open|June 8, 2026
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitusPrabhat Kumar Sharma, V Viswaprasad, Animesh Choudhary, et al.Metabolism Open|June 15, 2026
Ensemble learning uncovers novel metabolomic biomarkers for early osteoporosis prediction in Tibetan plateau populationsJiawei Yang, Tao Zhou, Haichen Zhang, et al.Metabolism Open|July 27, 2023
Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m2Akira Mima, Rina Lee, Ami Murakami, et al.Metabolism Open|July 3, 2023
Longitudinal changes in pancreatic volume and pancreatic fat with weight gain in Japanese without diabetes: An analysis using health check-up dataMaria Sunouchi, Jun Inaishi, Ryoko Shimizu-Hirota, et al.Metabolism Open|June 22, 2026
Corrigendum to "Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial" [Metabol Open 30 (2026) 100460]Prabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.Metabolism Open|June 22, 2026
What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges aheadMaria DalamagaPageof 44